Haleon sees higher sales in 2024 as FY profits come in flat
Haleon
382.00p
15:45 22/11/24
2.58%
9.60p
Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.
FTSE 100
8,260.10
15:45 22/11/24
n/a
n/a
FTSE 350
4,551.10
15:45 22/11/24
n/a
n/a
FTSE All-Share
4,506.61
15:45 22/11/24
n/a
n/a
Pharmaceuticals & Biotechnology
20,137.98
15:45 22/11/24
3.64%
707.65
The maker of Panadol pain relief, spun out of pharma giant GSK in 2022, posted pre-tax profits of £1.62bn for 2023, up 0.6%. It now expects revenue to rise 4% - 6% this year.
Revenue grew 4.1% to £11.3bn.
Reporting by Frank Prenesti for Sharecast.com